Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
MSD’s Ontruzant Gets Australian Reimbursement
Follows PBS listings for Ogivri, Herzuma and Kanjinti
Jan 08 2020
•
By
Aidan Fry
Merck Sharp & Dohme’s Ontruzant is now reimbursable in Australia • Source: Shutterstock
More from Biosimilars
More from Products